IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Atle Fund Management AB

Q3 2016 Holdings

Filed 2016-10-24 | 15 holdings | $19.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Charles RIV Labs Intl Inc(CRL)COM159864107$9.9M118,61250.1%
Anika Therapeutics Inc(ANIK)COM035255108$9.7M203,49349.3%
Cardinal Health Inc(CAH)COM14149Y108$17.9K230,8000.1%
Amerisourcebergen Corp(COR)COM03073E105$17.1K212,0000.1%
Anthem Inc(ELV)COM036752103$17.0K135,9000.1%
Inc Resh Hldgs IncCL A45329R109$9.9K222,8750.1%
GNC Hldgs IncCOM CL A36191G107$9.9K482,9550.1%
Merck & Co Inc(MRK)COM58933Y105$9.8K157,1000.0%
Triple-S Mgmt Corp(GTS)CL B896749108$9.4K429,9040.0%
Taro Pharmaceutical Inds LTDSHSM8737E108$9.4K85,2050.0%
Supernus Pharmaceuticals Inc(SUPN)COM868459108$9.4K379,5330.0%
Progenics Pharmaceuticals inCOM743187106$1.8K280,0000.0%
Immucell Corp(ICCC)COM PAR $0.10452525306$1.3K168,3230.0%
Spdr Series TrustBRCLYS 1-3MT ETF78464A680$91520,0000.0%
Ishares TR(SHY)1-3 YR TR BD ETF464287457$85010,0000.0%